Comparison of Dual Task Gait Characteristics in Individuals With Amputation and Healty Individuals

May 20, 2020 updated by: Senem Demirdel, Hacettepe University

Comparison of Cognitive and Motor Dual Task Gait Characteristics in Individuals With Transtibial, Transfemoral Amputation and Healty Individuals

In amputee, dual task has been found to cause a decrease in walking speed. However, there is no study of how gait characteristics are affected when the speed does not change. The aim of this study is to compare the time-distance characteristics of walking with single task, cognitive dual task, motor dual task in transtibial, transfemoral amputee and healthy people.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Walking is a complex task in which sensory and cognitive systems must be involved. The lower extremity amputee may need to use cognitive resources to focus on walking, monitor and control the prosthetic movements. The need to use cognitive resources may be higher in those with more proximal level amputation, such as above-knee level. The role of cognition and concentration is revealed by a cognitive task performed with posture and gait control using the dual task method. The dual task paradigm provides information about the automation of the default processes that underpin good performance disclosure. This approach involves performing two tasks at the same time. Dual task is divided into primary task and secondary task. The performance of the primary task while performing a single task is recorded. If there is a drop in performance when the secondary task is added, this indicates that the primary task needs high attention.

In proximal amputations, with the lost of movement system structures, functional impairment increases. Amputation from the proximal level affects daily life activities and walking ability more. Above-knee amputees reported more functional difficulties in ambulatory ambulation than transtibial amputee.

The aim of this study is to compare the time-distance characteristics of walking with single task, cognitive dual task, motor dual task in transtibial, transfemoral amputee and healthy people.

Study Type

Observational

Enrollment (Anticipated)

57

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altındağ
      • Ankara, Altındağ, Turkey, 06100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Transtibial amputees, Transfemoral amputees, Healty individuals

Description

Inclusion Criteria:

  • Using a transtibial or transfemoral prosthesis for at least 1 year,
  • Between the ages of 18-65,

Exclusion Criteria:

  • To be diagnosed as a neurological, orthopedic, cognitive disorder,
  • Having a condition other than amputation that may affect gait.
  • Having different permanent disabilities other than amputation,
  • Using walking aid,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Transtibial amputees
People who use transtibial prosthesis.
Participants will walk on the treadmill under single task, cognitive dual task and motor dual task conditions.
Transfemoral amputees
People who use transfemoral prosthesis.
Participants will walk on the treadmill under single task, cognitive dual task and motor dual task conditions.
Healty individuals
Participants will walk on the treadmill under single task, cognitive dual task and motor dual task conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking speed
Time Frame: Two minutes
Distance per second
Two minutes
Coefficient of variation
Time Frame: Two minutes
Stride length variability coefficient
Two minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Step length
Time Frame: Two minutes
Length of right and left steps in cm
Two minutes
Time on each foot
Time Frame: Two minutes
The period on right foot and left foot
Two minutes
Average step cycle
Time Frame: Two minutes
Yhe period of step cycle
Two minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 15, 2020

Primary Completion (ANTICIPATED)

June 12, 2021

Study Completion (ANTICIPATED)

June 15, 2022

Study Registration Dates

First Submitted

May 13, 2020

First Submitted That Met QC Criteria

May 13, 2020

First Posted (ACTUAL)

May 18, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 21, 2020

Last Update Submitted That Met QC Criteria

May 20, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • GO 20/23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on walking on the treadmill

Subscribe